Prognostic capacity of preoperative levels of selected blood inflammatory markers for glioma patient’s survival
Loading...
Date
2018-05
Authors
Yelaman, Konysbek
Journal Title
Journal ISSN
Volume Title
Publisher
Nazarbayev University School of Medicine
Abstract
Glioma is considered to be a rare type of cancer of the central nervous system (CNS)
with the average age-adjusted incidence rate of 3.4 per 100, 000 population. Moreover,
gliomas are the most common type of malignant brain tumors among adult population. They account for about 80% of all diagnosed brain tumors originating from brain parenchyma. Despite achievements in medical treatment and technologies glioblastoma patients still have poor prognosis with 3-5% of surviving patients after 12-15 months following standard therapy. In addition, recent studies highlight importance of blood, and molecular markers in predicting presence of gliomas.
Description
Keywords
Vascular endothelial growth factor, Isocitrate dehydrogenase, Glioma, central nervous system
Citation
Yelaman, Konysbek. (2018) Prognostic capacity of preoperative levels of selected blood inflammatory markers for glioma patient’s survival. Nazarbayev University School of Medicine